Trial Profile
A Randomized, Double-blind, Single-dose, Placebo Controlled, 2-way Cross-over Study Evaluating Effect of Albiglutide on Cholecystokinin-induced Gallbladder Emptying in Fasting Healthy Subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2023
Price :
$35
*
At a glance
- Drugs Albiglutide (Primary) ; Sincalide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 19 May 2017 Results published in the Journal of Clinical Pharmacology
- 18 Dec 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 16 Jul 2015 New trial record